Compass Therapeutics, Inc. (CMPX)

NASDAQ: CMPX · Real-Time Price · USD

2.400

+0.040 (1.69%)

At close: Aug 21, 2026, 4:00 PM EDT

2.381

-0.019 (-0.77%)

After-hours: Aug 21, 2026, 7:45 PM EDT

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	35.45	30.64	43.48	24.23	34.95	144.51
Short-Term Investments	144.43	178.26	83.24	128.23	151.66	-
Cash & Short-Term Investments	179.88	208.91	126.72	152.46	186.61	144.51
Cash Growth	78.19%	64.85%	-16.88%	-18.30%	29.13%	206.98%
Prepaid Expenses	1.01	0.91	6.03	1.42	8.18	2.59
Total Current Assets	180.89	209.82	132.75	153.88	194.79	147.11
Property, Plant & Equipment	8.72	9.2	7.08	2.67	4.53	6.33
Other Long-Term Assets	0.57	0.57	0.57	0.32	0.32	0.32
Total Assets	190.17	219.59	140.4	156.88	199.65	153.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.91	1.59	2.25	4.09	3.38	0.87
Accrued Expenses	11.59	11.38	6.29	2.51	11.69	8.78
Current Portion of Leases	1.64	1	0.34	1.2	1.1	0.99
Total Current Liabilities	16.13	13.97	8.87	7.8	16.17	10.63
Long-Term Leases	8	8.83	6.3	0.54	1.84	3.05
Total Liabilities	24.12	22.8	15.17	8.34	18.01	13.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	640.93	627.67	489.69	463.8	454.74	373.66
Retained Earnings	-474.64	-431.17	-364.68	-315.31	-272.81	-233.59
Comprehensive Income & Other	-0.25	0.28	0.21	0.04	-0.3	-
Total Common Equity	166.05	196.79	125.23	148.54	181.64	140.08
Shareholders' Equity	166.05	196.79	125.23	148.54	181.64	140.08
Total Liabilities & Equity	190.17	219.59	140.4	156.88	199.65	153.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.63	9.83	6.63	1.73	2.94	4.04
Net Cash (Debt)	170.25	199.08	120.09	150.73	183.67	140.48
Net Cash Growth	86.99%	65.78%	-20.33%	-17.94%	30.75%	272.20%
Net Cash Per Share	0.94	1.26	0.87	1.19	1.75	2.23
Filing Date Shares Outstanding	180.09	180.09	138.28	137.59	126.31	100.83
Total Common Shares Outstanding	180.09	178.32	137.82	127.67	126.3	100.83
Working Capital	164.76	195.85	123.88	146.08	178.62	136.47
Book Value Per Share	0.92	1.10	0.91	1.16	1.44	1.39
Tangible Book Value	166.05	196.79	125.23	148.54	181.64	140.08
Tangible Book Value Per Share	0.92	1.10	0.91	1.16	1.44	1.39
Machinery	4.94	4.76	4.74	5.19	5.16	5.37
Leasehold Improvements	1.61	1.61	1.61	1.61	1.61	1.53

SEC Filings: 10-K · 10-Q